JenaValve Technology is a global medical device company based in Wilmington, DE, dedicated to developing innovative technology for patients with structural heart disease. Their flagship product, the Trilogy System, is the only transcatheter aortic valve replacement (TAVR) solution specifically designed for severe aortic regurgitation. JenaValve is committed to supporting physicians and addressing the unmet needs of patients with this undertreated condition through their cutting-edge medical devices.
Generated from the website